Размер шрифта
Цветовая схема
Изображения
Форма
Межсимвольный интервал
Межстрочный интервал
стандартные настройки
обычная версия сайта
закрыть
  • Вход
  • Регистрация
  • Помощь
Выбрать БД
Простой поискРасширенный поискИстория поисков
Главная / Результаты поиска

Metabolic heterogeneity of cancer cells: An interplay between HIF-1, GLUTs, and AMPK

Moldogazieva N. T., Mokhosoev I. M., Terentiev A. A.
Cancers
Vol.12, Issue4, Num.862
Опубликовано: 2020
Тип ресурса: Обзор

DOI:10.3390/cancers12040862

Аннотация:
It has been long recognized that cancer cells reprogram their metabolism under hypoxia conditions due to a shift from oxidative phosphorylation (OXPHOS) to glycolysis in order to meet elevated requirements in energy and nutrients for proliferation, migration, and survival. However, data accumulated over recent years has increasingly provided evidence that cancer cells can revert from glycolysis to OXPHOS and maintain both reprogrammed and oxidative metabolism, even in the same tumor. This phenomenon, denoted as cancer cell metabolic plasticity or hybrid metabolism, depends on a tumor micro-environment that is highly heterogeneous and influenced by an intensity of vasculature and blood flow, oxygen concentration, and nutrient and energy supply, and requires regulatory interplay between multiple oncogenes, transcription factors, growth factors, and reactive oxygen species (ROS), among others. Hypoxia-inducible factor-1 (HIF-1) and AMP-activated protein kinase (AMPK) represent key modulat
Ключевые слова:
AMPK; Cancer metabolism; GLUTs; HIF-1; OXPHOS
fatty acid; glucose; glucose transporter; hamartin; hydroxymethylglutaryl coenzyme A reductase kinase; hypoxia inducible factor 1; K ras protein; liver kinase B1; mammalian target of rapamycin; Myc protein; oxygen; phosphatidylinositol 3 kinase; protein kinase B; protein p53; reactive oxygen metabolite; transcription factor; tumor suppressor protein; unclassified drug; aerobic metabolism; cancer cell; cell heterogeneity; cell hypoxia; cell metabolism; cell migration; cell proliferation; cell survival; drug targeting; energy resource; fatty acid oxidation; glycolysis; human; molecular interaction; nuclear reprogramming; nutrient supply; oncogene; oxidative phosphorylation; oxygen concentration; Review; tumor blood flow; tumor microenvironment; tumor vascularization
Язык текста: Английский
ISSN: 2072-6694
Moldogazieva N. T. Nurbubu Tentievna 1959-
Mokhosoev I. M.
Terentiev A. A.
Молдогазиева Н. Т. Нурбубу Тентиевна 1959-
Мохосоев И. М.
Терентиев А. А.
Metabolic heterogeneity of cancer cells: An interplay between HIF-1, GLUTs, and AMPK
Текст визуальный непосредственный
Cancers
Vol.12, Issue4 Num.862
2020
Обзор
AMPK Cancer metabolism GLUTs HIF-1 OXPHOS
fatty acid glucose glucose transporter hamartin hydroxymethylglutaryl coenzyme A reductase kinase hypoxia inducible factor 1 K ras protein liver kinase B1 mammalian target of rapamycin Myc protein oxygen phosphatidylinositol 3 kinase protein kinase B protein p53 reactive oxygen metabolite transcription factor tumor suppressor protein unclassified drug aerobic metabolism cancer cell cell heterogeneity cell hypoxia cell metabolism cell migration cell proliferation cell survival drug targeting energy resource fatty acid oxidation glycolysis human molecular interaction nuclear reprogramming nutrient supply oncogene oxidative phosphorylation oxygen concentration Review tumor blood flow tumor microenvironment tumor vascularization
It has been long recognized that cancer cells reprogram their metabolism under hypoxia conditions due to a shift from oxidative phosphorylation (OXPHOS) to glycolysis in order to meet elevated requirements in energy and nutrients for proliferation, migration, and survival. However, data accumulated over recent years has increasingly provided evidence that cancer cells can revert from glycolysis to OXPHOS and maintain both reprogrammed and oxidative metabolism, even in the same tumor. This phenomenon, denoted as cancer cell metabolic plasticity or hybrid metabolism, depends on a tumor micro-environment that is highly heterogeneous and influenced by an intensity of vasculature and blood flow, oxygen concentration, and nutrient and energy supply, and requires regulatory interplay between multiple oncogenes, transcription factors, growth factors, and reactive oxygen species (ROS), among others. Hypoxia-inducible factor-1 (HIF-1) and AMP-activated protein kinase (AMPK) represent key modulat